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Abstract: The application of plant extracts for therapeutic purposes has been used in traditional
medicine since the plants are a source of a great variety of chemical compounds that possess biological
activity. Actually, the effect of these extracts on diseases such as cancer is being widely studied.
Colorectal adenocarcinoma is one of the main causes of cancer related to death and the second most
prevalent carcinoma in Western countries. The aim of this work is to study the possible effect of two
fenugreek (Trigonella foenum graecum) protein hydrolysates on treatment and progression of colorectal
cancer. Fenugreek proteins from seeds were hydrolysed by using two enzymes separately, which are
named Purafect and Esperase, and were then tested on differentiated and undifferentiated human
colonic adenocarcinoma Caco2/TC7 cells. Both hydrolysates did not affect the growth of differentiated
cells, while they caused a decrease in undifferentiated cell proliferation by early apoptosis and
cell cycle arrest in phase G1. This was triggered by a mitochondrial membrane permeabilization,
cytochrome C release to cytoplasm, and caspase-3 activation. In addition, the hydrolysates of
fenugreek proteins displayed antioxidant activity since they reduce the intracellular levels of ROS.
These findings suggest that fenugreek protein hydrolysates could be used as nutraceutical molecules
in colorectal cancer treatment.
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1. Introduction
Fenugreek is one of the oldest plants used in traditional medicine. It has been used for a long time
due to its beneficial properties in the treatment of wounds, abscesses, arthritis, bronchitis, and digestive
disorders [1]. The seeds are the most important and useful part of the fenugreek plant [1]. Many of the
functional and medicinal properties of fenugreek are attributed to its chemical composition (20–25%
protein, 45–50% dietary fiber, 20–25% mucilaginous soluble fiber, 6–8% fatty acids and essential oils,
and 2–5% steroidal saponins) [2].
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Belguith-Hadriche, et al. [3] and Subhashini, et al. [4] demonstrated that seed fenugreek extracts
are effective against free radical mediated diseases. In addition, Madhava Naidu et al. [5] observed
that fenugreek husk, which is more rich in fiber, exhibits an important antioxidant property. However,
the proteins of fenugreek seeds, unlike other plants, have been barely investigated.
Legume proteins have become a topic of many studies on health being and certain disease
treatments. They are associated with a reduction in the incidence of various cancers, cholesterol,
type-2 diabetes, and heart disease [6]. Furthermore, protein hydrolysate has the additional advantage
of having improved functional properties as compared to the original protein isolates from which
they are prepared. This is due to the release of certain bioactive peptides, which are encoded in the
native protein molecule. More recently, potential health-promoting properties of peptides in these
hydrolysates have been discovered [7].
The antiproliferative property is among the numerous biological activities attributed to
hydrolysates. Effectively, several peptides with anticancer activity have been found in food protein
hydrolysates as well as colon antitumor activity of egg yolk proteins or the cytotoxic activity on human
colon carcinomas and mouse lymphoma cell lines of hydrophobic peptides extracted from soy [8].
The same findings have been reported in many other studies on Vicia faba protein hydrolysate [9],
common beans peptides [10], and rice brain peptides [11].
Even if the mechanisms underpinning the antiproliferative effect of the protein hydrolysates is not
well established, some hypotheses are proposed. For example, Ortiz-Martinez et al. [12] suggest that
the antiproliferative effect on HepG2 cells of peptide fractions isolated from maize albumin hydrolysate
is based on the induction of apoptosis due to the decrease of antiapoptotic factors expression. However,
Xue et al. [13] reported that a chickpea-derived peptide inhibits the proliferation of breast cancer cells
by increasing the p53 expression. Yet, Gao et al. [14] found that peptides derived from soy Vglycin
activate the expression levels of pro-apoptotic proteins and caspase-3.
Since colorectal cancer is one of the most commonly diagnosed cancers, and it is strongly influenced
by diet [8], the aim of this work has been to study the functional properties of the hydrolysed proteins
of fenugreek seeds in relation to the treatment of colon cancer. For this, we have measured the possible
antiproliferative and antioxidant effect of these hydrolysates on Caco-2 cells, and determined its
mechanism of action.
2. Materials and Methods
2.1. Fenugreek Protein Hydrolysates Preparation
Fenugreek was purchased from a local spices market in the city of Tiaret (Algeria). Seeds were
cleaned, grounded to a fine powder, and defatted in Soxhlet, (Labotech LT-6, Rosdorf, Germany), using
n-hexane for 12 cycles and their proteins were extracted at an isoelectric point (pH 4.5) according to
Boye et al. [15], as detailed previously [16]. The protein isolate was freeze dried and then hydrolyzed.
2.2. Preparation of FP Hydrolysates (FPHs)
Two hydrolysates were prepared from fenugreek proteins using Esperase® 0.8L (Sigma Chemical,
St. Louis, MO, USA) (pH 9; 50 ◦C) or Purafect® 2000E (Genencor International, Palo Alto, CA, USA)
(pH 10; 50 ◦C). FP were dissolved in distilled water at a proportion of 5% (w/v). Mixture pH and
temperature were adjusted to optimum enzyme activity prior its incorporation. The enzymes were
added to the solution at an enzyme/substrate ratio (E/S) of 5. Once the enzyme added, the mixture pH
was maintained constant by a continuous addition of 2N NaOH solution. The degree of hydrolysis
(DH) of FP was monitored by using a pH-stat method [17].
DH (%) =
h
htot
× 100 = B ×NB
MP
× 1
α
× 1
htot
× 100
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where B is the amount (mL) of NaOH consumed to keep the pH constant during the reaction, NB is
the normality of NaOH, MP is the mass of protein (g), and α is the average degree of dissociation of
the α-NH2 groups released during hydrolysis. htot is the total number of peptide bonds, which was
assumed to be 7.6 meq/g.
Hydrolysis was performed for 5 hours. Afterward, the reaction was stopped by heating the
solution at 90 ◦C for 10 min. Then, the digest was cooled at room temperature and centrifuged at
5000× g for 15 min. The obtained hydrolysates: Esperase-fenugreek proteins hydrolysate (EFPH) and
Purafect-fenugreek proteins hydrolysate (PFPH), were collected, freeze dried, and then stored at 4 ◦C.
2.3. Hydrolysates Proximate Composition
The protein, moisture, lipids, and ash contents in the freeze-dried fenugreek proteins and proteins
hydrolysates were determined by using the AOAC methods [18]. A factor of 6.25 was used to convert
the nitrogen value to protein. Minerals were analyzed by using Inductively Coupled Plasma-Optical
Emission Spectroscopy (ICP-OES, Perkin Elmer 4300DV, Shelton, CT, USA), after dissolving samples in
nitric acid (70%).
2.4. Amino Acid Analysis
A total of 50 µL of the sample (1 mg proteins/mL) were first hydrolyzed in a vacuum-sealed glass
tube for 24 h at 110 ◦C in the presence of 6 N HCl and 1% phenol. For tryptophane analysis, samples
were hydrolyzed in 4N NaOH, as described by Yust et al. [19]. At the end of hydrolysis, the samples
pH was adjusted to 7 and filtered through a 0.45 µm cellulose acetate membrane filter.
The samples were then analyzed by the reversed phase HPLC (Agilent 1100 HPLC
system, Wilmington, DE, USA) after automatic precolumn derivatization with a combination of
OPA-3MPA (o-phtaldialdehyde-3-mercaptopropionic acid) for primary amino acids and FMOC
(9-fluorenylmethylchloroformate) for secondary amino acids, following the manufacturer instructions.
The separation was done on a reversed-phase Zorbax Eclipse-AAA column (4.6 × 150 mm, 3.5 µm). The
quantification was determined by using norleucine as internal standard. The amino acid composition
was expressed as the percent of residues.
2.5. Cell Culture
The biological activity of fenugreek protein hydrolysates was evaluated on the human colonic
adenocarcinoma Caco2 cell line TC7 clone, provided by Dr. Edith Brot-Laroche (Université Pierre
et Marie Curie-Paris 6, UMR S 872, Les Cordeliers, France). Caco2/TC7 cells were maintained in a
humidified atmosphere of 5% CO2 at 37 ◦C. Cells (passages 38–41) were grown in Dulbecco’s Modified
Eagles Medium (DMEM) (Gibco Invitrogen, Paisley, UK) supplemented with 20% fetal bovine serum,
1% non-essential amino acids, and 1% amphotericin (250 U/mL). The cells were passaged enzymatically
with 0.25% trypsin-1 mM EDTA and sub-cultured on 25 cm2 plastic flasks at a density of 5 × 105 cells
per flask. Culture medium was replaced every three days. Cell confluence (80%) was confirmed by
the microscopic observance. Experiments were performed in differentiated cells and in cancerous or
undifferentiated cells (24 h post-seeding to prevent cell differentiation).
2.6. Cell Treatment and Antiproliferative Property Analysis
EFPH and PFPH were diluted in DMEM to the final concentration of 1 mg/mL. For an antiproliferative
experiment, 4 × 103 cells were dispensed into each well of a 96-well plate. The culture medium was
then replaced after 24 h with fresh medium (without fetal bovine serum, FBS) containing fenugreek
protein hydrolysates, with an exposure time of 24, 48, or 72 h. Untreated cells were taken as a
control. The anti-proliferative effect was measured with the sulforhodamine B assay, as described by
Sánchez-de-Diego et al. [20]. Cells were fixed with 10% trichloroacetic acid (1 h, 4 ◦C), washed with
distilled water, and stained with 4 g/L of sulforhodamine B (20 min, at room temperature). The plates
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were then washed with 1% acetic acid (v/v) to remove the unbound dye. Protein-bound dye was
extracted with 10 mM Tris base (pH 10.5). Untreated cells were taken as a control (C).
The same experiment was done with the differentiated cells. Lastly, the results were
obtained by measuring absorbance (A) with a scanning multi-well spectrophotometer (SPECTROstar
Nano Microplate Reader—BMG LABTECH, Ortenberg, Germany) at a wavelength of 562 nm.
The anti-proliferative effect was expressed as a percentage of living cells compared to the control, and
calculated as follows:
Viability (%) =
Asample
Acontrol
× 100
2.7. Apoptosis Measurement
Undifferentiated Caco2/TC7 cells were exposed for 24 h to 1 mg/mL of EFPH or PFPH, then
collected and stained with AnnexinV-FTIC in combination with propidium iodide (PI), as described by
Sánchez-de-Diego et al. [20]. Untreated cells were used as a negative control. After incubation, cells
were transferred to flow-cytometry tubes and washed twice with temperate phosphate-buffered saline
and re-suspended in 100 µL Annexin V binding buffer (10 mM Hepes/NaOH, pH 7.4, 140 mM NaCl,
2.5 mM CaCl2). Afterward, 5 µL of the Annexin V-FITC and 5 µL of PI were added to each 100 µL
of cell suspension. After incubation for 15 min at room temperature in the dark, 400 µL of Annexin
binding buffer were added and analyzed by flow cytometry within one hour. The signal intensity
was measured using a BD FACSAria (BD Biosciences, Piscataway, NJ, USA) and analyzed using BD
FACSDiva (BD Biosciences, San Jose, CA, USA).
2.8. Propidium Iodide Staining of DNA Content and Cell Cycle Analysis
The fenugreek protein hydrolysates treated Caco2/TC7 cells were fixed in 70% ice-cold ethanol
and stored at 4 ◦C for 24 h. After centrifugation (2500 rpm, 5 min), cells were rehydrated in PBS and
stained with propidium iodide (PI) solution (50 µg/mL) containing RNase A (100 µg/mL). PI stained
cells were analysed for DNA content in a BD FACSArray (BD Biosciences, Piscataway, NJ, USA). The
red fluorescence emitted by PI was collected by a 620-nm longer pass filter, as a measure of the amount
of DNA-bound PI and displayed on a linear scale. Cell cycle distribution was determined on a linear
scale. The results were treated with ModFit LT 3.0 (Verity Software House, Topsham, ME, USA) [20].
2.9. Mitochondrial Membrane Potential Assay by Flow Cytometry
Caco2/TC7 cells were plated in 25 cm2 flask at a density of 3 × 105 cells per flask and incubated
for 24 h under standard cell culture conditions. Afterward, cells were treated with 1 mg/mL of
fenugreek hydrolysates and incubated for 24 h. The control cells were incubated with a new
medium without treatment and without FBS. Then, cells were washed twice with temperate PBS and
re-suspended in temperate PBS at a concentration of 1 × 106 cells/mL. Later, 5 µL of 10 µM cationic dye
1,1′,3,3,3′-hexamethylindodicarbo-cyanine iodide (DiIC1) were added to each sample and the cells
were incubated 15 min at 37 ◦C, 5% CO2. After the incubation period, 400 µL of PBS were added to
each tube and fluorescence was analyzed by flow cytometry using a BD FACSArray equipped with an
argon ion laser. Excitation and emission settings were 633 and 658 nm, respectively.
2.10. Determination of Caspase 3 and Cytochrome C
Caco2/TC7 cells were plated in a 25 cm2 flask at a density of 3 × 105 cells per flask and incubated
for 24 h under standard cell culture conditions. Then, 1 mg/mL fenugreek hydrolysate solution was
added to the flask and incubated for 24 h.
The caspase-3 analysis were studied as previously described by Sánchez-de-Diego et al. [20].
The cells were fixed in 0.01% formaldehyde for 15 min and centrifuged for 5 min at 300× g. Then,
the pellet was suspended in 100 µL digitonin lysis buffer (50 mg/mL digitonin, 100 mM KCl, in 1× PBS)
and incubated for 15 min in the dark at room temperature (RT). After incubation, cells were washed
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with 2 mL of PBS containing 0.1% digitonin and centrifuged at 300× g for 5 min. The supernatant was
discarded and the pellet was re-suspended in 200 µL of PBS containing 0.1% digitonin. In addition,
2 µL of diluted caspase-3 antibody (Novus Biologicals, Abingdon, UK) were added to each sample and
the resultant mix was incubated for 1 hour. After incubation, cells were centrifuged at 500× g, for 5 min
at room temperature, and washed twice with PBS. Lastly, the cells were re-suspended in 400 µL of PBS.
Fluorescence was analyzed by flow cytometry (Ex: 494 nm, Em: 520 nm) using a BD FACSArray.
Cells with liberated cytochrome C were analyzed according to Christensen et al. [21] with slight
modifications [20]. Cells were initially resuspended thoroughly in 100 µL digitonin permeabilization
buffer (50 µg/mL digitonin; 100 mM KCl; in 1× PBS) followed by incubation for 5 min at room
temperature. This was followed by fixing the cells with 100 µL of 4% paraformaldehyde (PFA) in PBS
for 30 min. Centrifugation (500× g, 5 min) was carried out to remove PFA and cells were washed once
with 100 µL 1× PBS. Cells were then incubated with 100 µL blocking buffer (3% bovine serum albumin,
0.05% saponin, in 1× PBS) for 15 min at room temperature. Afterward, 2 µL of diluted cytochrome C
antibody 7H8-2C12 (Novus Biologicals, Abingdon, UK) was incubated with cells for 1 h. Cells were
washed twice with 1× PBS, then re-suspended in 400 µL of blocking buffer, and samples were analyzed
by flow cytometry (Ex: 488 nm, Em: 575 nm) in BD FACSArray.
2.11. Intracellular Levels of Reactive Oxygen Species (ROS)
The cells were seeded in 96-wells plate at a density of 4 × 103 cells/well. The intracellular level of
ROS was assessed using the dichlorofluorescein assay [22]. Caco2/TC7 cells were cultured for 24 h
before oxidative stress induction, and then incubated with 100 µL of serum-free culture media with
1 mg/mL of EFPH or PFPH for 24 h. After that, the medium was removed, cells were washed twice
with phosphate buffered saline, and incubated for 1 h with 100 µL of 20 µM 2′,7′-dichlorofluorescein
diacetate (DCFH-DA) in PBS at 37 ◦C. After this period, cells were washed and re-suspended in PBS
supplemented with 20 mM or 500 µM H2O2. The formation of the fluorescence oxidized derivative of
DCF was monitored at an emission wavelength of 535 nm and an excitation wavelength of 485 nm
in a multiplate reader. A measure at time “zero” was performed, cells were then incubated at 37 ◦C
in the multiplate reader, and generation of fluorescence was measured after 20 min. ROS levels
were expressed as a percentage of fluorescence (f ) compared to the control, and reported using the
following formula.
ROS levels (%) =
fsample
fControl
× 100× 100
Viability
2.12. Thioredoxin Reductase 1 (TrxR1) Activity Assay
Undifferentiated cells were seeded in a 96-well plate with different protein hydrolysates for 24 h.
The cells were then lysed (5 M NaCl, 1 M Tris-HCl pH 8.0, 0.5 M EDTA pH 8.0, SDS 10%, miliQ water)
and incubated in a shaking motion for 20 min. After the incubation time, 25 µL of the reaction mixture
(500 µL PBS pH 7.0, 80 µL, 100 mM EDTA pH 7.5, 20 µL 0.05% BSA, 100 µL 20 mM NADPH, 300 µL
H2O) were added to each well. Lastly, the reaction was started by adding 25 µL of 20 mM DTNB in pure
ethanol. The absorbance increase was followed at 405 nm every minute for 6 min. Wells with TrxR1
inhibitor (auranofin) were measured in the same conditions to subtract the unspecific activity [20]. Cell
protein contents were calculated by the Bradford method [23]. The result is expressed as a percentage
of TxrR1 activity of treated cells compared to the TxrR1 activity of C cells.
2.13. Statistical Analysis
Data are presented as mean ±SD. Data were subjected to one-way ANOVA and the LSD-Fisher
post hoc test. Differences were considered significant at p ≤ 0.05.
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3. Results
3.1. Kinetic and Degree of Hydrolysis
The hydrolysis curve of fenugreek proteins, illustrated in Figure 1, showed a first fast reaction
kinetics characterized by an initial rapid phase (during the first 60 min for Esperase and the first
15 min for Purafect). At the end of the hydrolysis reaction, the DHs of the protein isolate were 9% with
Purafect and 19% with Esperase.
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Figure 1. Kinetic of fenugreek proteins hydrolysis. E/S ratio= 5 U/mg proteins. EFPH: Esperase-fenugreek
proteins hydrolysate. PFPH: Purafect-fenugreek proteins hydrolysate.
3.2. Chemical and Amino Acids Composition of FP and FPHs
Sin e the propert e f protein hydrolysates depend strongly on their composition,
the physicochemical composition of fenugreek protein hydrolysates was first analyzed. The proximate
composition of EFPH and PFPH and their amino acid composition are shown in Table 1. Protein and
lipids contents in EFPH were higher when compared to PFPH.
Table 1. Chemical composition of fenugreek protein hydrolysates.
PFPH EFPH
(%) (%)
Proteins 89.9 ± 0.2 92.3 ± 0.5 *
HAA 49.4 49.0
AAA 16.8 17.2
PCAA 12.2 12.5
Lipids 2.8 ± 0.2 3.3 ± 0.4 *
Total fiber 3.0 ± 0.1 2.0 ± 0.1 *
Carbohydrates # 1.5 <1
Moisture 1.0 ± 0.1 1.1 ± 0.1
Ash 1.8 ± 0.2 1.3 ± 0.3
Mineral composition
Potassium (mg/100 g) 986 ± 5 1001 ± 1 *
Phosphorus (µg/g) 1933 ± 7 1927 ± 11
Sulphide (µg/g) 1128 ± 5 1268 ± 48 *
Magnesium (µg/g) 1013 ± 4 985 ± 9 *
Calcium (µg/g) 636 ± 2 502 ± 14 *
Sodium (µg/g) 122 ± 4 110 ± 3 *
Selenium (µg/kg) 53 ± 1 52 ± 1
PFPH: Purafect fenugreek proteins hydrolysate. EFPH: Esperase fenugreek proteins hydrolysate. HAA: hydrophobic
amino acids (Ala, Val, Ile, Leu, Tyr, Phe, Trp, Pro, Met, and Cys). AAA: aromatic amino acids (Phe, Tyr, Trp). PCAA:
positively charged amino acids (Arg, His, Lys). Results are presented as mean ± SD (n = 3). Superscripted (*) means
within a row are significantly different p ≤ 0.05). #: Calculated by difference.
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The bioactive properties of proteins hydrolysates are tightly related to the nature of their amino
acids (Maestri et al., 2018). Aromatic, hydrophobic, and positively charged amino acids were similar in
both hydrolysates. The detailed amino acids composition of fenugreek protein hydrolysates is reported
in Reference [16].
Potassium, sulphide, and phosphorus were the most abundant minerals in FPHs, while selenium
and sodium concentrations represented the less abundant.
3.3. Antiproliferative Activity
We first examined if the exposition of Caco2 TC7 cells to 1 mg/mL of FPH inhibits their proliferation.
The treatment of undifferentiated Caco2/TC7 cells with fenugreek proteins hydrolysates exhibited
a decrease in their viability. The PFPH anti-proliferative property was time dependent and passed
from 27% after 24 h to 55% after 72 h of the incubation period, compared to the control. With EFPH,
there was also a cells proliferation inhibitory effect, which varied between 39% and 50%. Nevertheless,
it was not significantly time dependent (Figure 2A). In order to demonstrate if the antiproliferative
effect of FPH found on Caco2/TC7 cells was specific for the undifferentiated cells or was a cytotoxic
mechanism, we tested this property on differentiated cells. There was no difference in differentiated
cell growth between the control and the treated cells (Figure 2B).
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Figure 2. Relative viability of undifferentiated ((A): 24 h, 48 h, and 72 h) and differentiated Caco2/TC7
cells (B) treated (24 h) or not with fenugreek proteins hydrolysates. Data are presented as mean ± SD.
The experiment was done in triplicate (each performed with six determinations). Superscripted (*)
means are significantly different (p ≤ 0.05) compared to their respective control. Control: Untreated
cells. PFPH: Purafect fenugreek proteins hydrolysate. EFPH: Esperase fenugreek proteins hydrolysate.
The hydrolysates were used at a final concentration of 1 mg/mL.
3.4. Apoptosis Analysis
major mechanisms could lead to cell death: necrosis and apoptosis. Necrosis is characterized
as passive, with uncontrolled release of inflammatory cellular contents. On the opposite side, apoptosis
is considered to be a regulated and controlled process that avoids eliciting inflammation [24]. Thus, we
examined which of t e two mechanisms was triggered by FPH. After 24 h of incubation with PFPH and
EFPH (final concentration 1 mg/mL) vs. untreated cells, u differentiated Caco2 living cells decreased.
Whereas, those with early apoptosis increase by 4.6-fold. There were no significant differences in cells
with late apoptosis or necrosis before a d after treatment (Figure 3).
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Figure 3. Effect of treating undifferentiated Caco2/TC7 cells with fenugreek proteins hydrolysates (24 h)
on apoptosis. (a) Representative histogram of cytometry analysis. (b) Cell death process repartition.
Data are presented as mean ± SD. The experiment was done in duplicate. Superscripted (*) means
are significantly different (p ≤ 0.05) when compared to their respective control. Control: Untreated
cells. PFPH: Purafect fenugreek proteins hydrolysate. EFPH: Esperase fenugreek proteins hydrolysate.
The hydrolysates were used at a final concentration of 1 mg/mL.
3.5. Cell Cycle Analysis
We subsequently analyzed if the treatment with 1 mg/mL of FPH caused a cell-cycle arrest in Caco2
TC7. Cell-cycle analysis (Figure 4) showed that cells stopped in the G0-G1 phase were, respectively,
1.6-fold and 1.5-fold hig er in PFPH and EFPH-treated cells compared to non-treated cells. In the S
phase, the cells treated with EFPH, and not those treated with PFPH, decreased by 40% vs. the control
cells. Even if there was a reduction in PFPH-treated cells blocked in the G2-M phase (−33%), this
difference was not statistically significant.
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3.6. Analysi of Mitochondrial Membrane Potential elease, and Caspase-3 Activation
Since FPH treatment (at 1 mg/mL) caused apoptosis in undifferentiated cells, we hypothesized
that it could induce mitochondrial permeabilization and cytochrome C release in Caco-2/TC7 cells.
Compared to non-treated cells, the number of cells exhibiting a changed in the mitochondrial membrane
potential (∆Ψm) increased by 70% in PFPH-treated and EFPH-treated cells. The results also showed
that, in treated cells, mitochondria cytochrome C contents decreased significantly compared to the
untreated cells.
The release of cytochrome C can lead to the activation of caspase 3, which is an executor of the
apoptosis pathway. The activated caspase-3 concentrations were significantly increased by 24-fold and
13-fold, respectively, in PFPH-treated and EFPH-treated cells when compared to the control (Table 2).
Table 2. Percentage of Caco2/CT7 cells with a positive mitochondrial membrane potential. Cells
with mitochondrial cytochrome C and active caspase-3, quantified by flow cytometry in response to
fenugreek proteins hydrolysates treatment (24 h).
Number of Cells (/100 Cells) Control PFPH EFPH
C lls with positive MMP 28.7 ± 10.9 69.2 ± 11.4 * 70.4 ± 4.1 *
Cells with mitochondrial cytochrome C 90.7 ± 1.6 71.3 ± 1.2 * 61.0 ± 9.8 *
Cells with active caspase-3 1.4 ± 0.0 33.3 ± 4.3 * 18.5 ± 3.8 *
Data are presented as mean ± SD. The experiment was done in duplicate. Superscripted (*) means within a row are
significantly different (p ≤ 0.05) when compared to their respective control. Control: untreated cells. PFPH: Purafect
fenugreek proteins hydrolysate. EFPH: Esperase fenugreek proteins hydrolysate. The hydrolysates were used at a
final concentration of 1 mg/mL. MMP: mitochondrial membrane potential.
3.7. Antioxidant Activity of FPH in Caco2 Cells
Oxidative stress is a characteristic state of many cancers, and it is implicated in cancer development
and progressio . The intracellular ROS levels, in the presence of high concentration of H2O2 (20 mM),
decreased by 35% in cells incubated with 1 mg/mL of EFPH when compared to the control. PFPH cells
did not exhibit any modification. However, in the presence of low concentrations of H2O2 (0.5 mM),
both treated cells exhibited better antioxidant activity vs. untreated cells. The inhibition reached 39%
and 33%, respectively, in EFPH and PFPH treated cells (final concentration 1 mg/mL) (Figure 5).
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Figure 5. Relative reactive oxygen species levels in undifferentiated Caco2/TC7 cells treated (24 h) or
not with fenugreek proteins hydrolysates. Data are presented as mean ± SD. The experiment was
done in triplicate (each performed with six determinations). Superscripted (*) means are significantly
different (p ≤ 0.05) compared to their respective control. Control: Untreated cells. PFPH: Purafect
fenugreek proteins hydrolysate. EFPH: Esperase fenugreek proteins hydrolysate. The hydrolysates
were used at a final concentration of 1 mg/mL.
3.8. Thioredoxin Reductase 1 Activity
Since FPH induced a decrease in intracellular ROS levels in Caco2 TC7, we proposed to study
whether this decrease is caused by up-regulated enzyme activities or not. Hence, we proposed to
measure the activity of one of the most important cellular antioxidant enzyme: thioredoxin reductase.
TrxR1 activity was lower in PFPH (−41%) and EFPH (−12%) treated cells vs. control cells (Figure 6).
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Figure 6. Relative thioredoxin reductase activity in undifferentiated Caco2/TC7 cells treated (24 h) or
not with fenugreek proteins hydrolysates. Data are presented as mean ± SD. The experiment was
done in dup icat (each performe with six determinations). Superscripted (*) mean are significantly
different (p ≤ 0.05) compared to their respec ive control. Control: Untreated c lls. PFPH: Purafect
fenugr ek proteins hydrolysate. EFPH: Esp ase fenugreek roteins hydrolysate. Th hydrolysa es
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4. Discussion
The anticancer property of natural products became one of the most studied topics. In recent
years, the studies on plant proteins and peptides have increased, which is motivated by their huge
diversity, affordability, and lack of side effects. Legumes are the plant source for which most peptides
with anticancer properties are reported [25]. Fenugreek is a legume-rich protein, which could be a
potential source of biological active peptides.
The hydrolysis curve of fenugreek proteins was typical of many protein hydrolysates obtained
by Sbroggio et al. [26] with okara hydrolysates. The differences in hydrolysis shape and DH values
were probably due to the difference in enzyme specificity. On the other hand, the DH could inform the
peptides’ mean size [17]. Hence, EFPH with DH = 19% could contain smaller peptides than PFPH.
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Our results suggest that protein contents of the hydrolysates are important. These findings were
in line with Pownall et al. [27] and Mundi and Aluko [28]. The high protein content could be a result of
the solubilisation of peptides during hydrolysis. It is speculated that the hydrolysis, especially when
alkaline enzymes are used, enhance the solubilisation of proteins and removes insoluble undigested
non-protein substances [29].
Even if the amino acids profile showed that aromatic and hydrophobic amino acids did not differ
between the hydrolysates, these values are higher than those found by other authors [27,28,30].
After analyzing the FPH composition, we tried to check if FPH possesses an anti-proliferative
property in cells. The treatment of undifferentiated Caco2/TC7 cells with FPH exhibited a decrease in
their viability, especially with PFPH that was correlated with incubation time. These results are in
line with works reporting an anti-proliferative property of peptides and hydrolysates from soy [14],
corn [12,31], chickpeas [13], and rice [11] on different cell models. Vglycin, a peptide isolated from soy,
inhibited the proliferation of three types of colon cancer cells [14]. Ortiz-Martinez et al. [12] also found
that corn peptide fractions decreased HepG2 cells growth by more than 50%. Li et al. [31] noticed
that this antiproliferative property was time-dependent. In addition, a pentapeptide from rice brane
showed 84% of viability inhibition on colon cancer cells [11].
Caco2/TC7 differentiated cell viability was not influenced by the FPH treatment. Same observation,
in normal and cancer oral cells, was also reported by Kumar et al. [32] with a chickpea protein fraction.
Ours findings could indicate a possible selective antiproliferative effect of PFPH and EFPH on cancer
cells without affecting the normal cells.
One of the possible ways by which FPH inhibited the cancerous cells could be the same mechanism
seen with antimicrobial peptides when they act as anticancer agents as well. It is believed that normal
cells exhibit an asymmetric composition between the internal and the external layers of their membrane.
In cancer cells, this asymmetry is affected principally by the externalization of phosphatidylserine
(normally confined to the inner leaflet), and the external layer of cancer cell membranes that will carry
a net negative charge. This permits an electrostatic interaction between cationic anticancer peptides
and anionic cell membrane components [33].
It seemed interesting to investigate if FPH could induce the anti-proliferative effect by apoptosis.
The study with EPFH and PEPH was carried out in undifferentiated cells by flow cytometry analysis after
staining with annexin V/propidium iodide. Since cells in early apoptosis express phosphatidylserine
in their outer side of the cytoplasmic membrane, they will be stained by Annexin-V labelled with
FITC (early apoptosis). However, membranes of dead and damaged cells are permeable to propidium
iodide (necrosis) and are also stained with annexin-V (late apoptosis) [20]. It seemed that PFPH and
EFPH set off an early apoptosis mechanism, rather than necrosis, in undifferentiated cells. In this way,
Ortiz-Martinez et al. [12] showed that HepG2 cells treated with corn peptide fractions have a four-fold
increase of both early and late apoptotic events, compared to the untreated cells. Similarly, Li et al. [31]
remarked that corn peptides generated apoptosis in 11% to 55% of HepG2 cells in a dose-dependent
manner. Moreover, Vglycin treatment for 24 hours caused a significant increase of apoptosis in different
colon cancer cells [14].
With apoptotic and no necrotic property, PFPH and EFPH seem to have a beneficial effect against
cancer cells. Additionally, in this work, it was found that both FPH stimulated the early apoptosis,
which is favored to the late one since it allows early recognition of dead cells [34].
By analyzing the effect of fenugreek proteins hydrolysates on cell cycles, it is suggested that both
hydrolysates caused mainly a cell cycle arrest in the G1 phase, which has also been shown in other
studies. In this way, Gao et al. [14] deduced that soy Vglycin induced a G1-phase arrest of colorectal
cancer cells. Li et al. [31] indicated that corn peptides could induce HepG2 cell cycle arrest in the S
phase. The hemagglutinin caused cell cycle arrest in the G2/M phase, as demonstrated by Lam and
Ng [35].
Many studies have shown associations between some minerals and carcinogenesis. Mg2+ ions are
enzyme cofactors involved in DNA repair mechanisms that maintain genomic stability and fidelity.
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Magnesium deficiency may also be associated with inflammation and increased levels of free radicals
where both inflammatory mediators and free radicals arising could cause oxidative DNA damage
and, therefore, tumor formation [36]. There is also evidence that dietary Ca2+ loading reduces colon
cell proliferation and carcinogenesis [37]. The presence of these two elements in FPH could also
be responsible for their anti-proliferative properties. According to Kasprzak [38], the molecular
mechanisms involved in the effects of such minerals are likely to include binding at chromatin
(e.g., DNA, histones, transcription factors, DNA repair enzymes) and other regulatory molecules in the
target cells.
Apoptosis manifests in two major execution programs downstream of the death signal: the caspase
pathway and organelle dysfunction of which mitochondrial dysfunction is best characterized [39]. To see
if the apoptotic action of FPH was led by these mechanisms, we analyzed, by flow cytometry, the change
in mitochondrial membrane potential, cytochrome C in the mitochondria, and the cytoplasmic level of
the active form of caspase-3.
Mitochondria play a pivotal role in life and death of the cell since it produces the majority of energy
required for survival and regulates the intrinsic pathway of apoptosis. The involvement of mitochondria
in cell death is generally measured by following mitochondrial membrane depolarisation [21].
FPH-treated cells showed a higher change in mitochondrial membrane potential. Disruption of
the mitochondrial outer membrane permeability leads to the release of proteins confined in the
intermembrane space into the cytosol. These proteins include the apoptogenic factors, such as
cytochrome C, which plays a crucial role in activating the mitochondrial-dependent death in the
cytosol [32].
With the aim to discover whether PFPH and EFPH were able to induce mitochondrial
permeabilization and cytochrome C release, we used flow cytometry to analyze the mitochondrial
cytochrome C in treated and untreated cells. The results showed that, in treated cells, there was a
greater cytochrome C release to cytoplasm than in the untreated cells. Once cytochrome C is released to
the cytoplasm, it could activate different proteins of the intrinsic apoptosis pathway such as the effector
caspase-3 [40]. Once caspase-3 is activated, it induces the proteolytic cleavage of a large number of
essential proteins for apoptosis [41]. Moreover, caspase-3 is a prototypical executioner caspase that,
upon activation by extrinsic and intrinsic pathways, cleaves a wide panel of several substrates that are
vital for the cell, which precipitates regulated cell death. It is also responsible for modulating some
enzyme activities like those required for the exposure of phosphatidylserine (PS) on the outer leaflet of
dying cells [42].
Activated caspase-3 concentrations were increased in PFPH and EFPH treated cells. Gao et al. [14]
also confirmed that Vglycin promoted caspase-3 activity in colon cancer cells. The same results were
obtained by Li et al. [31], with corn peptides on HepG2 cells.
Higher levels of ROS are generated through the increased metabolic activity of cancer cells
including enhanced signalling pathways or mitochondrial dysfunction [43]. The ROS levels in Caco2
cells were determined based on the reaction between ROS and DCFH-DA [13].
In our assays, Fenugreek protein hydrolysates showed antioxidant power. EFPH showed a better
ROS inhibitory property even though PFPH was not effective with high levels of ROS. In this way,
when HepG2 cells were incubated with 100 µM of peroxide, the corn peptides fraction could not
decrease the peroxide-ROS generation [12]. In contrast, Xue et al. [13] showed that chickpea peptides
decreased the ROS in MCF-7 and MDA-MB-231 cells. Torres-Fuentes et al. [44] and Zhang et al. [45]
reported an antioxidant property of chickpea and soy proteins hydrolysates in Caco2 cells.
A study undertaken by Chi et al. [46] confirmed that peptides with a smaller molecular size,
the presence of hydrophobic and aromatic amino acid residues, and the amino acid sequences were
the key factors that determine the antioxidant activities of hydrolysates and peptides. Fenugreek
protein hydrolysates are rich in hydrophobic and aromatic amino acids [16]. Moreover, as the cells
incubated with protein hydrolysates were washed, some peptides may be lost since they are not able
to cross the cell membrane due to their big size and polarity. However, small hydrophobic peptides
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are able to cross this membrane and stay in the cytoplasm, where they may exert their antioxidant
property [44]. EFPH in which DH is higher than that of PFPH (19% vs. 9%, respectively) has higher
ROS inhibition activity.
Because of the increase in ROS production in tumor cells, it is concerted that many antioxidants
and redox control systems are up regulated. One of the most important cellular redox systems is the
thioredoxin (Trx) system, comprised of Trx, TrxR1, and NADPH [43]. However, in our study, TrxR1
activity was found to be lower in both FPH-treated cells. Since the antioxidant enzymes activities are
up-regulated following an increase of ROS production in cancer cells, we supposed that the decrease in
TrxR1 could result from the low levels of ROS in treated cells (low stimuli of Trx and TrxR1 expression),
and not a direct inhibition of the enzyme by FPH.
5. Conclusions
This data demonstrated that Purafect and Esperase fenugreek protein hydrolysates possess a
selective antiproliferative property on colorectal cancer cells, by enhancing intrinsic apoptosis rather
than necrosis on Caco2/TC7, and by blocking the cell cycle in the G1 phase. Both hydrolysates induced
alteration in mitochondrial membrane permeability, induced cytochrome C release to the cytoplasm,
and induced caspase-3 activation. Furthermore, these two hydrolysates exerted an antioxidant activity
by inhibiting the reactive oxygen species. In light of these results, fenugreek proteins hydrolysates
could represent a promising nutraceutical in the treatment and progression of colon cancer. Future
studies will be interesting to perform in order to see if these fenugreek protein hydrolysates are also
effective in other types of cancer cells and in vivo animal models.
Author Contributions: A.B. and M.J.R.-Y. were responsible for the overall direction of the research. A.A. performed
the experiments, analysis of data, and wrote the manuscript. S.G. performed and supervised the experiments.
S.B. and J.Q. performed a part of the experiments. J.O. contributed with materials and analysis results. M.N.
supervised the hydrolysis processes. A.A. performed cell culture experiments supervised by M.J.R.-Y. A.B. and
M.J.R.-Y. analyzed the obtained data. All authors have given approval to the final version of the manuscript.
Funding: The Spanish Ministry of Economy and Innovation under Grant (SAF 2016-75441-R); Aragón Regional
Government (A-32 B16-R17), CIBERobn under Grant (CB06/03/1012) of the Instituto de Salud Carlos III,
European Grant Interreg/SUDOE (Redvalue, SOE1/PI/E0123), and the Algerian Ministry of Higher Education,
Scientific Research and the Tunisian Ministry of Higher Education and Scientific Research (Joint Research Project
Algeria/Tunisia 137/2012) supported this research.
Acknowledgments: Authors thank Centro de Investigation Biomédica de Aragón (Spain) for technical assistance
(http://www.iacs.aragon.es). Authors also thank the Regional Laboratory of Quality Control and Fraud Repression
of Oran (Algeria) for their help with amino acid composition analysis of fenugreek protein hydrolysates.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Meghwal, M.; Goswami, T.K. A Review on the functional properties, nutritional content, medicinal utilization
and potential application of fenugreek. J. Food Process. Technol. 2012, 3, 181–190. [CrossRef]
2. Khorshidian, N.; Asli, M.Y.; Arab, M.; Mirzaie, A.A.; Mortazavian, A.M. Fenugreek: Potential applications as
a functional food and nutraceutical. Nutr. Food Sci. Res. 2016, 3, 5–16. [CrossRef]
3. Belguith-Hadriche, O.; Bouaziz, M.; Jamoussia, K.; Simmonds, M.; El Feki, A.; Makni-Ayedi, F. Comparative
study on hypocholesterolemic and antioxidant activities of various extracts of fenugreek seeds. Food Chem.
2013, 138, 1448–1453. [CrossRef] [PubMed]
4. Subhashini, N.; Thangathirupathi, A.; Lavanya, N. Antioxidant activity of Trigonella foenum graecum using
various in vitro and ex vivo models. J. Pharm. Pharm. Sci. 2011, 3, 96–102.
5. Madhava Naidu, M.; Shyamala, B.N.; Pura Naik, J.; Sulochanamma, G.; Srinivas, P. Chemical composition
and antioxidant activity of the husk and endosperm of fenugreek seeds. Food Sci. Technol. 2011, 44, 451–456.
[CrossRef]
6. Roy, F.; Boye, J.I.; Simpson, B.K. Bioactive proteins and peptides in pulse crops: Pea, chickpea and lentil.
Food Res. Int. 2010, 43, 432–442. [CrossRef]
Nutrients 2019, 11, 724 14 of 15
7. Girón-Calle, J.; Vioque, J.; Pedroche, J.; Alaiz, M.; Yust, M.M.; Megías, C.; Millán, F. Chickpea protein
hydrolysate as a substitute for serum in cell culture. Cytotechnology 2008, 57, 263–272. [CrossRef] [PubMed]
8. Zambrowicz, A.; Timmer, M.; Polanowski, A.; Lubec, G.; Trziszka, T. Manufacturing of peptides exhibiting
biological activity. Amino Acids 2013, 44, 315–320. [CrossRef] [PubMed]
9. León-Espinosa, E.B.; Sánchez-Chino, X.; Garduño-Siciliano, L.; Álvarez-González, R.I.; Dávila-Ortiz, G.;
Madrigal-Bujaidar, E.; Téllez-Medina, D.I.; Jiménez-Martínez, C. Hypocholesterolemic and anticarcinogenic
effect of Vicia faba protein hydrolyzates. Nutr. Cancer 2016, 68, 856–864. [CrossRef]
10. Luna Vital, D.A.; González de Mejía, E.; Dia, V.P.; Loarca-Piña, G. Peptides in common bean fractions inhibit
human colorectal cancer cells. Food Chem. 2014, 157, 347–355. [CrossRef]
11. Kannan, A.; Hettiarachchy, N.S.; Lay, J.O.; Liyanage, R. Human cancer cell proliferation inhibition by a
pentapeptide isolated and characterized from rice bran. Peptides 2010, 31, 1629–1634. [CrossRef] [PubMed]
12. Ortiz-Martinez, M.; de Mejia, E.G.; García-Lara, S.; Aguilar, O.; Lopez-Castillo, L.M.; Otero-Pappatheodorou, J.T.
Antiproliferative effect of peptide fractions isolated from a quality protein maize, a white hybrid maize, and
their derived peptides on hepatocarcinoma human HepG2 cells. J. Funct. Foods 2017, 34, 36–48. [CrossRef]
13. Xue, Z.; Wen, H.; Zhai, L.; Yu, Y.; Li, Y.; Yu, W.; Cheng, A.; Wang, C.; Kou, X. Antioxidant activity and
anti-proliferative effect of a bioactive peptide from chickpea (Cicer arietinum L.). Food Res. Int. 2015, 77, 75–81.
[CrossRef]
14. Gao, C.; Sun, R.; Xie, Y.R.; Jiang, A.L.; Lin, M.; Li, M.; Chen, Z.W.; Zhang, P.; Jin, H.; Feng, J.P. The soy-derived
peptide Vglycin inhibits the growth of colon cancer cells in vitro and in vivo. Exp. Boil. Med. 2017, 242,
1034–1043. [CrossRef] [PubMed]
15. Boye, J.I.; Aksay, S.; Roufik, S.; Ribéreau, S.; Mondor, M.; Farnworth, E.; Rajamohamed, S.H. Comparison of
the functional properties of pea, chickpea and lentil protein concentrates processed using ultrafiltration and
isoelectric precipitation techniques. Food Res. Int. 2010, 43, 537–546. [CrossRef]
16. Allaoui, A.; Barranquero, C.; Yahia, S.; Herrera-Marcos, L.V.; Benomar, S.; Jridi, M.; Navarro-Ferrando, M.Á.;
Rodriguez-Yoldi, M.J.; Nasri, M.; Osada, J.; et al. Fenugreek proteins and their hydrolysates prevent
hypercholesterolemia and enhance the HDL antioxidant properties in rats. Nutr. Food Sci. 2018, 48, 973–989.
[CrossRef]
17. Adler-Nissen, J. A review of food hydrolysis specific areas. In Enzymic Hydrolysis of Food Proteins;
Adler-Nissen, J., Ed.; Elsevier Applied Science Publishers: Copenhagen, Dermark, 1986; pp. 57–109.
18. Horwitz, W. Food composition; additives; natural contaminants. In Official Methods of Analysis of AOAC
International, 17th ed.; Horwitz, W., AOAC International, Eds.; AOAC International: Gaithersburg, MD, USA,
2000; Volume 2.
19. Yust, M.M.; Pedroche, J.; Girón-Calle, J.; Vioque, J.; Millán, F.; Alaiz, M. Determination of tryptophan
by high-performance liquid chromatography of alkaline hydrolysates with spectrophotometric detection.
Food Chem. 2004, 85, 317–320. [CrossRef]
20. Sánchez-de-Diego, C.; Mármol, I.; Pérez, R.; Gascón, S.; Rodriguez-Yoldi, M.J.; Cerrada, E. The anticancer
effect related to disturbances in redox balance on Caco-2 cells caused by an alkynyl gold(I) complex.
J. Inorg. Biochem. 2017, 166, 108–121. [CrossRef] [PubMed]
21. Christensen, M.E.; Jansen, E.S.; Sanchez, W.; Waterhouse, N.J. Flow cytometry based assays for the
measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release.
Methods 2013, 61, 138–145. [CrossRef] [PubMed]
22. Ruiz-Leal, M.; George, S. An in vitro procedure for evaluation of early stage oxidative stress in an established
fish cell line applied to investigation of PHAH and pesticide toxicity. Mar. Environ. Res. 2004, 58, 631–635.
[CrossRef] [PubMed]
23. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248–254. [CrossRef]
24. Fink, S.L.; Cookson, B.T. Apoptosis, pyroptosis, and necrosis: Mechanistic description of dead and dying
eukaryotic cells. Infect. Immun. 2005, 73, 1907–1916. [CrossRef]
25. Ortiz-Martinez, M.; Winkler, R.; García-Lara, S. Preventive and therapeutic potential of peptides from cereals
against cancer. J. Proteom. 2014, 111, 165–183. [CrossRef]
26. Sbroggio, M.F.; Montilha, M.S.; de Figueiredo, V.R.G.; Georgetti, S.R.; Kurozawa, L.E. Influence of the degree
of hydrolysis and type of enzyme on antioxidant activity of okara protein hydrolysates. Food Sci. Technol.
2016, 36, 375–381. [CrossRef]
Nutrients 2019, 11, 724 15 of 15
27. Pownall, T.L.; Udenigwe, C.C.; Aluko, R.E. Amino acid composition and antioxidant properties of pea
seed (Pisum sativum L.) enzymatic protein hydrolysate fractions. J. Agric. Food Chem. 2010, 58, 4712–4718.
[CrossRef]
28. Mundi, S.; Aluko, R.E. Inhibitory properties of kidney bean protein hydrolysate and its membrane fractions
against renin, angiotensin converting enzyme, and free radicals. Austin J. Nutr. Food Sci. 2014, 2, 1008.
29. Kristinsson, H.G.; Rasco, B.A. Fish protein hydrolysates: Production, biochemical, and functional properties.
Crit. Rev. Food Sci. Nutr. 2000, 40, 43–81. [CrossRef]
30. Yust, M.d.M.; Millán-Linares, M.d.C.; Alcaide-Hidalgo, J.M.; Millán, F.; Pedroche, J. Hypocholesterolaemic
and antioxidant activities of chickpea (Cicer arietinum L.) protein hydrolysates. J. Sci. Food Agric. 2012, 92,
1994–2001. [CrossRef]
31. Li, J.T.; Zhang, J.L.; He, H.; Ma, Z.L.; Nie, Z.K.; Wang, Z.Z.; Xu, X.G. Apoptosis in human hepatoma HepG2
cells induced by corn peptides and its anti-tumor efficacy in H22 tumor bearing mice. Food Chem. Toxicol.
2013, 51, 297–305. [CrossRef]
32. Kumar, S.; Kapoor, V.; Gill, K.; Singh, K.; Xess, I.; Das, S.N.; Dey, S. Antifungal and antiproliferative protein
from Cicer arietinum: A bioactive compound against emerging pathogens. BioMed Res. Int. 2014, 2014, 387203.
[CrossRef]
33. Hoskin, D.W.; Ramamoorthy, A. Studies on anticancer activities of antimicrobial peptides. Biochim. Biophys.
Acta Biomembr. 2008, 1778, 357–375. [CrossRef]
34. Pistritto, G.; Trisciuoglio, D.; Ceci, C.; Garufi, A.; D’Orazi, G. Apoptosis as anticancer mechanism: Function
and dysfunction of its modulators and targeted therapeutic strategies. Aging 2016, 8, 603–619. [CrossRef]
35. Lam, S.K.; Ng, T.B. Apoptosis of human breast cancer cells induced by hemagglutinin from Phaseolus vulgaris
cv. Legumi secchi. Food Chem. 2011, 126, 595–602. [CrossRef]
36. Blaszczyk, U.; Duda-Chodak, A. Magnesium: Its role in nutrition and carcinogenesis. Roczniki Pan´stwowego
Zakładu Hig. 2013, 64, 165–171.
37. Whitfield, J. Calcium, calcium-sensing receptor and colon cancer. Cancer Lett. 2009, 275, 9–16. [CrossRef]
38. Kasprzak, K.S. Effects of calcium, magnesium, zinc, and iron on nickel carcinogenesis: Inhibition versus
enhancement. In Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment;
Hadjiliadis, N.D., Ed.; Springer: Dordrecht, The Netherlands, 1997; Volume 26, pp. 93–106.
39. Zhang, F.L.; Wang, P.; Liu, Y.H.; Liu, L.B.; Liu, X.B.; Li, Z.; Xue, Y.X. Topoisomerase I inhibitors, shikonin and
topotecan, inhibit growth and induce apoptosis of glioma cells and glioma stem cells. PLoS ONE 2013, 8,
e81815. [CrossRef]
40. Riedl, S.J.; Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Boil.
2004, 5, 897–907. [CrossRef]
41. Slee, E.A.; Adrain, C.; Martin, S.J. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles
during the demolition phase of apoptosis. J. Boil. Chem. 2001, 276, 7320–7326. [CrossRef]
42. Galluzzi, L.; López-Soto, A.; Kumar, S.; Kroemer, G. Caspases connect cell-death signaling to organismal
homeostasis. Immunity 2016, 44, 221–231. [CrossRef]
43. Bhatia, M.; McGrath, K.L.; Di Trapani, G.; Charoentong, P.; Shah, F.; King, M.M.; Clarke, F.M.; Tonissen, K.F.
The thioredoxin system in breast cancer cell invasion and migration. Redox Biol. 2016, 8, 68–78. [CrossRef]
44. Torres-Fuentes, C.; del María, C.M.; Isidra, R.; Manuel, A.; Javier, V. Identification and characterization
of antioxidant peptides from chickpea protein hydrolysates. Food Chem. 2015, 180, 194–202. [CrossRef]
[PubMed]
45. Zhang, Q.; Tong, X.; Sui, X.; Wang, Z.; Qi, B.; Li, Y.; Jiang, L. Antioxidant activity and protective effects of
Alcalase-hydrolyzed soybean hydrolysate in human intestinal epithelial Caco-2 cells. Food Res. Int. 2018,
111, 256–264. [CrossRef] [PubMed]
46. Chi, C.F.; Hu, F.Y.; Wang, B.; Li, Z.R.; Luo, H.Y. Influence of amino acid compositions and peptide profiles
on antioxidant capacities of two protein hydrolysates from skipjack tuna (Katsuwonus pelamis) dark muscle.
Mar. Drugs 2015, 13, 2580–2601. [CrossRef] [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
